Atrial fibrillation (AF) poses significant healthcare challenges due to its complex nature and association with increased morbidity and mortality. Effective management requires a comprehensive understanding of its pathophysiology, diagnosis, and treatment strategies.
AF results from chaotic electrical activity in the atria, leading to irregular and often rapid heart rate. The key pathophysiological factors include atrial remodeling, autonomic imbalance, and inflammation. Understanding these mechanisms can inform targeted therapeutic strategies.
Diagnosis of AF involves a combination of patient history, physical examination, and electrocardiographic (ECG) evidence. Continuous ECG monitoring may be necessary for paroxysmal AF. Additional investigations like echocardiography can provide valuable information about structural heart disease contributing to AF.
The primary goals of AF management are stroke prevention and symptom control. Anticoagulation is crucial for stroke prevention, with the choice of agent guided by stroke risk scores. Symptom control involves rate or rhythm control strategies, depending on patient characteristics and preferences. Catheter ablation may be considered for symptomatic AF refractory to medical therapy.
Given the chronic nature of AF and the potential side effects of treatment, patient education and shared decision-making are vital. Understanding patient preferences and values can guide the choice between rate and rhythm control strategies, and between different anticoagulation options.
Mastering AF management involves a comprehensive understanding of AF pathophysiology, a systematic approach to diagnosis, and individualized treatment strategies. Emphasizing patient education and shared decision-making can improve treatment adherence and patient outcomes. As healthcare professionals, we must continually update our knowledge and skills in AF management to provide the best patient care.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation